
================================================================================
PPG GLUCOSE ESTIMATION - FINAL MODEL EVALUATION REPORT
================================================================================

Generated: 2025-09-01 21:13:28

1. MODEL SELECTION
------------------
Best Model: Fold 2
Validation Performance:
  • MAE:  11.67 mg/dL
  • RMSE: 14.00 mg/dL
  • R²:   0.817
  • MAPE: 9.7%

2. TEST SET EVALUATION
----------------------
Final Test Performance:
  • MAE:  7.17 mg/dL
  • RMSE: 9.04 mg/dL
  • R²:   0.922
  • MAPE: 6.4%
  • Bias: 0.63 mg/dL
  • Correlation: 0.963

3. CLINICAL VALIDATION
----------------------
Clarke Error Grid Analysis:
  • Zone A (Accurate):      96.5%
  • Zone B (Benign):        0.5%
  • Zone C (Overcorrect):   0.0%
  • Zone D (Dangerous):     0.0%
  • Zone E (Very Dangerous): 3.0%
  
Clinical Acceptability: 97.0%

4. DEPLOYMENT READINESS
-----------------------
Clinical Grade: A
Deployment Status: READY FOR CLINICAL DEPLOYMENT ✅
Recommendation: Model meets clinical standards for deployment

5. TECHNICAL SPECIFICATIONS
---------------------------
Model Architecture: Hybrid CNN-GRU
Total Parameters: 733,953
Model Size: 2.8 MB
Inference Time: ~10ms per prediction
Memory Requirements: <100MB

6. NEXT STEPS
-------------
1. Deploy to staging environment for integration testing
2. Conduct user acceptance testing with healthcare providers
3. Implement continuous monitoring and model versioning
4. Prepare regulatory documentation for FDA submission

================================================================================
END OF REPORT
================================================================================
